TSXV:IFX - Post Discussion
Post by
Torontojay on Mar 23, 2023 10:00am
Pfb corp purchase price multiple.
I owned Pfb corp when it was acquired for $24.1 a share. At the time, the trailing P/E multiple was ~ 10.5 and a price to sales multiple of slightly above 1. The company was acquired in late 2021.
Imaflex and Pfb corp are comparable due to similar input costs; namely, resin. In the last 12 months Imaflex has sales of $115.4 m compared to a market cap of ~ $89 m. Pfb was also in a strong net cash position at the time of purchase.
Imaflex current P/E ratio is ~ 8.76
Both P/S and P/E ratios for Imaflex are trading slightly below Pfb at time of acquisition but probably closer to par when you remove excess cash from PFB.
Be the first to comment on this post